BIM 26226

Known as: BIM-26226, BIM26226 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2001
012319942001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
BACKGROUND AND AIMS The main goal of our study was to characterise the activity of BIM26226 as a peripheral gastrin releasing… (More)
Is this relevant?
2001
2001
BACKGROUND & AIMS This study was designed to characterize [D-F(5)Phe(6)D-Ala(11)]Bn(6-13)OMe (BIM26226) as a gastrin-releasing… (More)
Is this relevant?
1998
1998
Acute intracerebroventricular (i.c.v.) administration of bombesin (BN) reduces meal intake in fasted rats. The overall objective… (More)
Is this relevant?
1997
1997
Bombesin was originally isolated from amphibian skin, whereas its mammalian counterpart, gastrin-releasing peptide (GRP), was… (More)
Is this relevant?
1996
1996
BACKGROUND Exogenous gastrin-releasing peptide (GRP) stimulates the release of secretin from the small intestine and… (More)
Is this relevant?
1996
1996
The growth of the human gastrinoma model (PT) in athymic nude mice is stimulated by bombesin (BBS), an amphibian peptide… (More)
  • table 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
Receptors for the bombesin family of peptides are present on human and guinea pig respiratory tract submucosal glands and mediate… (More)
Is this relevant?
1995
1995
The effect of somatostatin analogue, lanreotide, and bombesin/GRP antagonist, BIM 26226, on the growth of colon cancer peritoneal… (More)
Is this relevant?
1994
1994
Using AR4-2J rat pancreatic carcinoma cells, the effects of a novel bombesin (BN) receptor antagonist [D-F5Phe6, D-Ala11]BN(6-13… (More)
Is this relevant?